0
0
London – A leading UK charity, Prostate Cancer UK, has issued a stark warning that thousands of men may be undergoing unnecessary and potentially harmful treatment for low-risk prostate cancer. The organization attributes this issue to “outdated guidelines” from the National Institute of Health and Care Excellence (NICE).
According to the charity, up to 5,000 men each year could be affected, enduring treatments like radiotherapy or surgery when a less invasive approach, known as active surveillance, would suffice. These unnecessary procedures can lead to significant side effects, including erectile dysfunction and incontinence, severely impacting a patient’s quality of life.
The current NICE guidelines, which were last updated in 2021, have failed to incorporate recent advances in diagnostic technologies. This has led to a “wild west” scenario where different hospitals and healthcare providers apply surveillance protocols inconsistently. This variation has created a “postcode lottery,” with overtreatment rates fluctuating dramatically from 2% to 24% across England.
Prostate Cancer UK is urging NICE to revise its guidance to ensure all men with low-risk prostate cancer are offered active surveillance as a primary option, promoting a more consistent and appropriate standard of care nationwide. The charity highlighted the positive experience of individuals who have successfully managed their condition with active surveillance for years without needing more aggressive treatment.
Disclaimer: This article is for informational purposes only and does not constitute medical advice. Consult with a qualified healthcare professional for diagnosis, treatment, and medical decisions.
Reference:
